Apollon Wealth Management, LLC Fulgent Genetics, Inc. Transaction History

Apollon Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$37.92 - $63.74 $110,536 - $185,802	2,915 Added 66.33%	7,310 $279,000
Q2 2022 Aug 11, 2022	BUY	$47.98 - $62.75 $3,022 - $3,953	63 Added 1.45%	4,395 $240,000
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $32,901 - $63,432	-660 Reduced 13.22%	4,332 $270,000
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $4,483 - $6,090	-58 Reduced 1.15%	4,992 $502,000
Q3 2021 Nov 15, 2021	BUY	$74.87 - $110.87 $55,254 - $81,822	738 Added 17.12%	5,050 $454,000
Q2 2021 Aug 12, 2021	BUY	$66.8 - $100.45 $41,215 - $61,977	617 Added 16.7%	4,312 $398,000
Q1 2021 May 17, 2021	BUY	$59.3 - $183.85 $219,113 - $679,325	3,695 New	3,695 $357,000

198

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $504M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Apollon Wealth Management, LLC with notifications on news.